---
layout: report
type: daily
topic_slug: multiple_sclerosis
topic_display: "Multiple Sclerosis"
date: 2025-09-12
run_id: multiple_sclerosis_20250912_060611
theme: "Beyond DMTs: Managing Common MS Symptoms (Pain, Spasticity, Bladder Issues)"
persona: "Persona.INFORMED_PATIENT"
source_plan_path: "/home/runner/work/health_buddy_app/health_buddy_app/.results/multiple_sclerosis/weekly_plan/2025-09-08/plan.json"
permalink: /topics/multiple_sclerosis/daily/2025-09-12/multiple_sclerosis_20250912_060611/
title: "Multiple Sclerosis â€” 2025-09-12"
---

# Multiple Sclerosis: Beyond DMTs - Managing Common MS Symptoms (Pain, Spasticity, Bladder Issues)

Living with Multiple Sclerosis (MS) means actively managing daily symptoms to maintain quality of life, complementing disease-modifying therapies (DMTs). This summary explores recent advancements and practical strategies for tackling common MS symptoms: pain, spasticity, and bladder issues.

### Pain Management Beyond Standard Approaches

Neuropathic pain is frequent in MS. Beyond traditional medications, personalized strategies are key. **Interdisciplinary pain clinics** offer non-pharmacological interventions like advanced physical therapy, focusing on movement re-education (e.g., specific exercises to improve gait and balance) and posture correction (e.g., ergonomic adjustments). Look for physical therapists specializing in neurological rehabilitation. Cognitive Behavioral Therapy (CBT) and mindfulness-based stress reduction (MBSR) help reframe pain perception; seek certified therapists. For persistent, localized pain, like trigeminal neuralgia or specific neuropathic pain, **nerve blocks or radiofrequency ablation** may offer targeted, temporary relief when other methods fail. These are generally FDA-approved for pain management, with potential for temporary soreness or bruising.

### Innovative Approaches to Spasticity

Spasticity, causing muscle stiffness and spasms, severely impacts mobility. While oral medications like baclofen and tizanidine are common, they can cause drowsiness, muscle weakness, or dizziness. Newer, targeted approaches offer alternatives.

**Intrathecal baclofen pumps** involve a surgical implant that delivers medication directly to the spinal cord, reducing systemic side effects and providing profound relief for severe, generalized spasticity unresponsive to oral meds. Risks include infection, catheter issues, pump malfunction, or baclofen withdrawal if refills are missed. Regular pump refills are essential.

**Botulinum toxin injections** (e.g., FDA-approved OnabotulinumtoxinA, AbobotulinumtoxinA, IncobotulinumtoxinA) effectively treat focal spasticity in specific muscle groups (e.g., upper or lower limbs), offering 3-4 months of relief. Side effects are typically temporary muscle weakness or injection site discomfort.

Beyond medications, progressive resistance training and stretching, guided by a physical therapist, are crucial. Specialized bracing and orthotics can also provide support and reduce abnormal muscle tone.

### Addressing Bladder Issues with Advanced Solutions

Bladder dysfunction (urgency, frequency, incontinence) affects most MS patients. Anticholinergic medications can cause dry mouth, constipation, blurred vision, or cognitive effects, prompting a search for newer strategies.

**Pelvic floor physical therapy** is a highly effective, non-invasive treatment involving exercises (like Kegels), biofeedback, bladder training, and urge suppression techniques. Seek physical therapists with specialized certification in pelvic health or neurological conditions.

**Neuromodulation techniques** are increasingly used for refractory cases. **Sacral nerve stimulation (SNS)** involves a two-stage surgical procedure (test phase, then permanent implant) to stimulate nerves controlling bladder function. FDA-approved for refractory overactive bladder or non-obstructive urinary retention, risks include infection, lead migration, or device malfunction requiring battery replacement. **Percutaneous tibial nerve stimulation (PTNS)**, FDA-approved, involves weekly 30-minute sessions for 12 weeks, followed by monthly maintenance, with generally mild, temporary ankle discomfort.

**Urodynamic studies** measure bladder capacity, pressure, urine flow, and muscle function during filling and emptying. These insights help identify specific bladder dysfunction (e.g., overactive bladder, poor emptying) to tailor treatment.

These advancements highlight a shift towards holistic, personalized symptom management in MS, empowering patients with diverse strategies to enhance daily life.
